Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma × Indocyanine Green × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Neoplasms 13 Lung Neoplasms 11 Stomach Neoplasms 10 Endometrial Neoplasms 10 Head and Neck Neoplasms 7 Carcinoma, Hepatocellular 7 Lymphatic Metastasis 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Colonic Neoplasms 4 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2 Margins of Excision 2 Giant Cell Tumor of Bone 2

Interventions

Bupivacaine 2 Ultrasonography 1 Therapeutics 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ralfinamide 1 Radiofrequency Ablation 1 Nerve Conduction Studies 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Lidoderm 1 Lidocaine 1 Indocyanine Green 1 Dry Needling 1 Decompression 1 Cryosurgery 1 Cholecalciferol 1 Bevacizumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡